Mail Outreach To Increase Vaccination Acceptance Through Engagement (MOTIVATE)
Influenza, Human, Influenza, Human Flu
About this trial
This is an interventional treatment trial for Influenza, Human focused on measuring Vaccination, Immunization, Randomized Controlled Trial, Prevention & Control, Preventive Measures, Health Promotion, Medicare, Intention Prompts, Letters
Eligibility Criteria
Sites / Locations
- Centers for Medicare & Medicaid Services
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
No Intervention
Experimental
Experimental
Experimental
Experimental
No letter
Core letter signed by Surgeon General
Core letter signed by Director of the National Vaccine Program
Core letter signed by Surgeon General + implementation prompt
Core letter signed by SG + enhanced implementation prompt
Individuals randomized to the control group who will not receive any of the four letters
Individuals randomized to receive only a core letter signed by the Surgeon General
Individuals randomized to receive only a core letter signed by the Director of the National Vaccine Program
Individuals randomized to receive a core letter signed by the Surgeon General with an implementation intention prompt added in an appended P.S. tag region below the signature line
Individuals randomized to receive a core letter signed by the Surgeon General (SG) with an enhanced implementation intention prompt added in an appended P.S. tag region below the signature line